@phdthesis{Gerhard2011, author = {Gerhard, Sven}, title = {AlGaInP-Quantenpunkte f{\"u}r optoelektronische Anwendungen im sichtbaren Spektralbereich}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-76174}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2011}, abstract = {Die Arbeit besch{\"a}ftigt sich mit der Herstellung und Charakterisierung von AlGaInP Quantenpunkten auf GaP und GaAs-Substrat. Auf Basis dieser Quantenpunkte wurden Halbleiterlaser auf GaAs hergestellt, welche bei Raumtemperatur zwischen 660 nm und 730 nm emittierten. Die Untersuchung von Breitstreifenlasern, welche aus diesen Strukturen gefertigt wurden, legen nahe, dass man mithilfe eines h{\"o}heren Aluminiumanteils in gr{\"o}ßeren Quantenpunkten bei vergleichbarer Wellenl{\"a}nge Laser mit besseren Eigenschaften realisieren kann. Weiterhin wurden in dieser Arbeit Quantenpunkten auf GaP-Substrat untersucht, welche in AlGaP eingebettet wurden. Da diese Quantenpunkte in Barrieren eingebettet sind, welche eine indirekte Bandl{\"u}cke besitzen, ergibt sich ein nicht-trivialer Bandverlauf innerhalb dieser Strukturen. In dieser Arbeit wurden numerische 3D-Simulationen verwendet, um den Bandverlauf zu berechnen, wobei Verspannung und interne Felder ber{\"u}cksichtigt wurden und auch die Grundzustandswellenfunktionen ermittelt wurden. Ein eingehender Vergleich mit dem Experiment setzt die gemessenen Emissionswellenl{\"a}ngen und -intensit{\"a}ten mit berechneten {\"U}bergangsenergien und {\"U}berlappintegralen in Verbindung.}, subject = {Quantenpunkt}, language = {de} } @article{IrmerTarazonaSasseetal.2015, author = {Irmer, Henriette and Tarazona, Sonia and Sasse, Christoph and Olbermann, Patrick and Loeffler, J{\"u}rgen and Krappmann, Sven and Conesa, Ana and Braus, Gerhard H.}, title = {RNAseq analysis of Aspergillus fumigatus in blood reveals a just wait and see resting stage behavior}, series = {BMC Genomics}, volume = {16}, journal = {BMC Genomics}, number = {640}, doi = {10.1186/s12864-015-1853-1}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-151390}, year = {2015}, abstract = {Background: Invasive aspergillosis is started after germination of Aspergillus fumigatus conidia that are inhaled by susceptible individuals. Fungal hyphae can grow in the lung through the epithelial tissue and disseminate hematogenously to invade into other organs. Low fungaemia indicates that fungal elements do not reside in the bloodstream for long. Results: We analyzed whether blood represents a hostile environment to which the physiology of A. fumigatus has to adapt. An in vitro model of A. fumigatus infection was established by incubating mycelium in blood. Our model allowed to discern the changes of the gene expression profile of A. fumigatus at various stages of the infection. The majority of described virulence factors that are connected to pulmonary infections appeared not to be activated during the blood phase. Three active processes were identified that presumably help the fungus to survive the blood environment in an advanced phase of the infection: iron homeostasis, secondary metabolism, and the formation of detoxifying enzymes. Conclusions: We propose that A. fumigatus is hardly able to propagate in blood. After an early stage of sensing the environment, virtually all uptake mechanisms and energy-consuming metabolic pathways are shut-down. The fungus appears to adapt by trans-differentiation into a resting mycelial stage. This might reflect the harsh conditions in blood where A. fumigatus cannot take up sufficient nutrients to establish self-defense mechanisms combined with significant growth.}, language = {en} } @article{GerhardHartmannGoergenBroeckelmannetal.2022, author = {Gerhard-Hartmann, Elena and Goergen, Helen and Br{\"o}ckelmann, Paul J. and Mottok, Anja and Steinm{\"u}ller, Tabea and Grund, Johanna and Zam{\`o}, Alberto and Ben-Neriah, Susana and Sasse, Stephanie and Borchmann, Sven and Fuchs, Michael and Borchmann, Peter and Reinke, Sarah and Engert, Andreas and Veldman, Johanna and Diepstra, Arjan and Klapper, Wolfram and Rosenwald, Andreas}, title = {9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial}, series = {British Journal of Haematology}, volume = {196}, journal = {British Journal of Haematology}, number = {1}, doi = {10.1111/bjh.17793}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-258358}, pages = {116-126}, year = {2022}, abstract = {High programmed cell death 1 ligand 1 (PD-L1) protein expression and copy number alterations (CNAs) of the corresponding genomic locus 9p24.1 in Hodgkin- and Reed-Sternberg cells (HRSC) have been shown to be associated with favourable response to anti-PD-1 checkpoint inhibition in relapsed/refractory (r/r) classical Hodgkin lymphoma (cHL). In the present study, we investigated baseline 9p24.1 status as well as PD-L1 and major histocompatibility complex (MHC) class I and II protein expression in 82 biopsies from patients with early stage unfavourable cHL treated with anti-PD-1-based first-line treatment in the German Hodgkin Study Group (GHSG) NIVAHL trial (ClinicalTrials.gov Identifier: NCT03004833). All evaluated specimens showed 9p24.1 CNA in HRSC to some extent, but with high intratumoral heterogeneity and an overall smaller range of alterations than reported in advanced-stage or r/r cHL. All but two cases (97\%) showed PD-L1 expression by the tumour cells in variable amounts. While MHC-I was rarely expressed in >50\% of HRSC, MHC-II expression in >50\% of HRSC was found more frequently. No obvious impact of 9p24.1 CNA or PD-L1 and MHC-I/II expression on early response to the highly effective anti-PD-1-based NIVAHL first-line treatment was observed. Further studies evaluating an expanded panel of potential biomarkers are needed to optimally stratify anti-PD-1 first-line cHL treatment.}, language = {en} }